PMC:7326681 / 13032-13214 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T37","span":{"begin":15,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A37","pred":"fma_id","subj":"T37","obj":"http://purl.org/sig/ont/fma/fma9601"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T32","span":{"begin":15,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A32","pred":"uberon_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T108","span":{"begin":15,"end":28},"obj":"Disease"},{"id":"T109","span":{"begin":22,"end":28},"obj":"Disease"},{"id":"T110","span":{"begin":115,"end":123},"obj":"Disease"}],"attributes":[{"id":"A108","pred":"mondo_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T85","span":{"begin":15,"end":21},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"T86","span":{"begin":84,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T37","span":{"begin":48,"end":51},"obj":"Chemical"}],"attributes":[{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_28939"},{"id":"A38","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_7421"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T52","span":{"begin":15,"end":28},"obj":"Phenotype"},{"id":"T53","span":{"begin":86,"end":91},"obj":"Phenotype"},{"id":"T54","span":{"begin":175,"end":181},"obj":"Phenotype"}],"attributes":[{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0003002"},{"id":"A53","pred":"hp_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A54","pred":"hp_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/HP_0100806"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-sentences","denotations":[{"id":"T91","span":{"begin":0,"end":182},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T129","span":{"begin":15,"end":21},"obj":"UBERON:0000310"},{"id":"T130","span":{"begin":48,"end":51},"obj":"CHEBI:7586;CHEBI:7586"},{"id":"T131","span":{"begin":115,"end":123},"obj":"SP_7"},{"id":"T88061","span":{"begin":15,"end":21},"obj":"UBERON:0000310"},{"id":"T90640","span":{"begin":48,"end":51},"obj":"CHEBI:7586;CHEBI:7586"},{"id":"T57885","span":{"begin":115,"end":123},"obj":"SP_7"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}

{"project":"LitCovid-PubTator","denotations":[{"id":"389","span":{"begin":48,"end":51},"obj":"Gene"},{"id":"392","span":{"begin":29,"end":37},"obj":"Species"},{"id":"400","span":{"begin":15,"end":28},"obj":"Disease"},{"id":"401","span":{"begin":86,"end":91},"obj":"Disease"},{"id":"402","span":{"begin":115,"end":123},"obj":"Disease"},{"id":"403","span":{"begin":175,"end":181},"obj":"Disease"}],"attributes":[{"id":"A389","pred":"tao:has_database_id","subj":"389","obj":"Gene:7504"},{"id":"A392","pred":"tao:has_database_id","subj":"392","obj":"Tax:9606"},{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"MESH:D001943"},{"id":"A401","pred":"tao:has_database_id","subj":"401","obj":"MESH:D005334"},{"id":"A402","pred":"tao:has_database_id","subj":"402","obj":"MESH:C000657245"},{"id":"A403","pred":"tao:has_database_id","subj":"403","obj":"MESH:D018805"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Medications in breast cancer patients receiving NAC can suppress the development of a fever or other symptoms, and COVID-19 disease may remain asymptomatic until they develop sepsis."}